Andrew M Moon1, Brenda Curtis2, Pranoti Mandrekar3, Ashwani K Singal4,5, Elizabeth C Verna6, Oren K Fix1. 1. Division of Gastroenterology and Hepatology University of North Carolina School of Medicine Chapel Hill NC USA. 2. National Institute on Drug Abuse Intramural Research Program Baltimore MD USA. 3. Department of Medicine University of Massachusetts Medical School Worcester MA USA. 4. Department of Medicine University of South Dakota Sanford School of Medicine Sioux Falls SD USA. 5. Division of Transplant Hepatology Avera Transplant Institute Sioux Falls SD USA. 6. Center for Liver Disease and Transplantation Columbia University New York NY USA.
Abstract
The Coronavirus Disease 2019 (COVID-19) pandemic has exacted a heavy toll on patients with alcohol-associated liver disease (ALD) and alcohol use disorder (AUD). The collective burden of ALD and AUD was large and growing, even before the COVID-19 pandemic. There is accumulating evidence that this pandemic has had a large direct effect on these patients and is likely to produce indirect effects through delays in care, psychological strain, and increased alcohol use. Now a year into the pandemic, it is important that clinicians fully understand the effects of the COVID-19 pandemic on patients with ALD and AUD. To fill existing gaps in knowledge, the scientific community must set research priorities for patients with ALD regarding their risk of COVID-19, prevention/treatment of COVID-19, changes in alcohol use during the pandemic, best use of AUD treatments in the COVID-19 era, and downstream effects of this pandemic on ALD. Conclusion: The COVID-19 pandemic has already inflicted disproportionate harms on patients with ALD, and ongoing, focused research efforts will be critical to better understand the direct and collateral effects of this pandemic on ALD.
The Coronavirus Disease 2019 (COVID-19) pandemic has exacted a heavy toll on patients with alcohol-associated liver disease (ALD) and alcohol use disorder (AUD). The collective burden of ALD and AUD was large and growing, even before the COVID-19 pandemic. There is accumulating evidence that this pandemic has had a large direct effect on these patients and is likely to produce indirect effects through delays in care, psychological strain, and increased alcohol use. Now a year into the pandemic, it is important that clinicians fully understand the effects of the COVID-19 pandemic on patients with ALD and AUD. To fill existing gaps in knowledge, the scientific community must set research priorities for patients with ALD regarding their risk of COVID-19, prevention/treatment of COVID-19, changes in alcohol use during the pandemic, best use of AUD treatments in the COVID-19 era, and downstream effects of this pandemic on ALD. Conclusion: The COVID-19 pandemic has already inflicted disproportionate harms on patients with ALD, and ongoing, focused research efforts will be critical to better understand the direct and collateral effects of this pandemic on ALD.
Authors: Thoetchai Bee Peeraphatdit; Patrick S Kamath; Victor M Karpyak; Brian Davis; Vivek Desai; Suthat Liangpunsakul; Arun Sanyal; Naga Chalasani; Vijay H Shah; Douglas A Simonetto Journal: Clin Gastroenterol Hepatol Date: 2019-04-28 Impact factor: 11.382
Authors: Bridget F Grant; S Patricia Chou; Tulshi D Saha; Roger P Pickering; Bradley T Kerridge; W June Ruan; Boji Huang; Jeesun Jung; Haitao Zhang; Amy Fan; Deborah S Hasin Journal: JAMA Psychiatry Date: 2017-09-01 Impact factor: 21.596
Authors: Andrea DiMartini; Lubna Javed; Sarah Russell; Mary Amanda Dew; Mary Grace Fitzgerald; Ashok Jain; John Fung Journal: Liver Transpl Date: 2005-06 Impact factor: 5.799
Authors: Brian P Lee; Eric Vittinghoff; Jennifer L Dodge; Giuseppe Cullaro; Norah A Terrault Journal: JAMA Intern Med Date: 2019-03-01 Impact factor: 21.873
Authors: Thomas Marjot; Andrew M Moon; Jonathan A Cook; Sherief Abd-Elsalam; Costica Aloman; Matthew J Armstrong; Elisa Pose; Erica J Brenner; Tamsin Cargill; Maria-Andreea Catana; Renumathy Dhanasekaran; Ahad Eshraghian; Ignacio García-Juárez; Upkar S Gill; Patricia D Jones; James Kennedy; Aileen Marshall; Charmaine Matthews; George Mells; Carolyn Mercer; Ponni V Perumalswami; Emma Avitabile; Xialong Qi; Feng Su; Nneka N Ufere; Yu Jun Wong; Ming-Hua Zheng; Eleanor Barnes; Alfred S Barritt; Gwilym J Webb Journal: J Hepatol Date: 2020-10-06 Impact factor: 25.083
Authors: Thomas Marjot; Gwilym J Webb; Alfred S Barritt; Andrew M Moon; Zania Stamataki; Vincent W Wong; Eleanor Barnes Journal: Nat Rev Gastroenterol Hepatol Date: 2021-03-10 Impact factor: 73.082
Authors: George N Ioannou; Peter S Liang; Emily Locke; Pamela Green; Kristin Berry; Ann M O'Hare; Javeed A Shah; Kristina Crothers; McKenna C Eastment; Vincent S Fan; Jason A Dominitz Journal: Hepatology Date: 2021-06-02 Impact factor: 17.298